ClinConnect ClinConnect Logo
Search / Trial NCT06583967

The Effect of Aerobic Exercise on an Elliptical Trainer Versus a Treadmill, in People with Multiple Sclerosis

Launched by SOROKA UNIVERSITY MEDICAL CENTER · Sep 1, 2024

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

Aerobic Exercise Elliptical Trainer Treadmill 6 Minute Walk Test (6 Mwt) Timed Up & Go (Tug) Berg Balance Scale (Bbs) 10 Meter Walk Test (10 Mwt) Informed Consent Form (Icf)

ClinConnect Summary

This clinical trial is looking at how aerobic exercise can help people with Multiple Sclerosis (MS) improve their walking abilities. Specifically, it will compare the effects of exercising on an elliptical trainer versus using a treadmill. The study aims to see which type of exercise better helps with balance, stability, and walking speed in individuals with moderate MS.

To take part in this study, participants need to be between 25 and 55 years old, have been diagnosed with MS for at least six months, and be able to stand steadily for at least 30 seconds. Participants should not have engaged in regular physical training, like walking or using exercise machines, for the three months before the study. If eligible, individuals will be recruited for exercise sessions that aim to improve their mobility and overall well-being. It's important to note that people with certain health conditions, like heart or lung diseases, may not be able to participate.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients signed Informed Consent Form
  • 2. At least 6 months post MS diagnosis
  • 3. 25-55 years old adults
  • 4. EDSS 3.0-6.5
  • 5. Standing stability - for at least 30 seconds
  • 6. 6MWT - minimal distance to be measured as 210 meters
  • 7. No physical routinely training e.g. walking, elliptical or cycling within 3 months prior screening visit.
  • Exclusion Criteria:
  • 1. Active Heart Disease
  • 2. Lungs and/or respiratory system diseases
  • 3. Metabolic Disease
  • 4. Any other medical condition(s) which might impact the patient's participant in the study, as per PI medical judgement
  • 5. Major medical treatment change (as per PI medical judgement) up to 12 weeks prior ICF signature by the patient.

About Soroka University Medical Center

Soroka University Medical Center is a leading academic medical institution located in Beer Sheva, Israel, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a key player in the Israeli healthcare system, Soroka integrates cutting-edge medical practice with extensive educational programs, fostering a collaborative environment for researchers, clinicians, and students. The center specializes in a wide range of medical fields, emphasizing patient-centered care and evidence-based practices. With a focus on advancing medical knowledge and improving patient outcomes, Soroka University Medical Center actively sponsors and conducts clinical trials that contribute to significant breakthroughs in various therapeutic areas.

Locations

Beer Sheva, , Israel

Ramat Gan, , Israel

Patients applied

0 patients applied

Trial Officials

Iuly Treger, MD, PhD

Principal Investigator

Soroka University Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported